Physiological and pathophysiological roles for phospholipase D

Journal of Lipid Research

Volumn 56, Issue 12, 2015, Pages 2229-2237

  Nelson, Rochelle K ^a   Frohman, Michael A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Cancer; Lipid signaling; Phosphatidic acid

Indexed keywords

PHOSPHOLIPASE D; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; PHOSPHOLIPASE D3; PHOSPHOLIPASE D4; PHOSPHOLIPASE D5; PHOSPHOLIPASE D6; UNCLASSIFIED DRUG; PHOSPHATIDIC ACID;

ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME REGULATION; ENZYME STRUCTURE; FIBROSIS; HUMAN; INFLUENZA; MOLECULAR PATHOLOGY; NEXT GENERATION SEQUENCING; NONHUMAN; PHENOTYPE; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; METABOLISM; MOUSE; NEOPLASM; PHYSIOLOGY;

ANIMALS; MICE; NEOPLASMS; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE D; SIGNAL TRANSDUCTION;

EID: 84937237384     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R059220     Document Type: Review

References (116)

1. Jenkins, G. M., and M. A. Frohman . 2005 . Phospholipase D: A lipid centric review. Cell. Mol. Life Sci. 62 : 2305 - 2316 .
2. Sung, T. C., R. L. Roper, Y. Zhang, S. A. Rudge, R. Temel, S. M. Hammond, A. J. Morris, B. Moss, J. Engebrecht, and M. A. Frohman . 1997 . Mutagenesis of phospholipase D defi nes a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity. EMBO J. 16 : 4519 - 4530 .
3. Selvy, P. E., R. R. Lavieri, C. W. Lindsley, and H. A. Brown . 2011 . Phospholipase D: Enzymology, functionality, and chemical modulation. Chem. Rev. 111 : 6064 - 6119 .
4. Alling, C., L. Gustavsson, and E. Anggård . 1983 . An abnormal phospholipid in rat organs after ethanol treatment. FEBS Lett. 152 : 24 - 28 .
5. Frohman, M. A. 2015 . The phospholipase D superfamily as therapeutic targets. Trends Pharmacol. Sci. 36 : 137 - 144 .
6. Gnann, H., A. Thierauf, F. Hagenbuch, B. Röhr, and W. Weinmann . 2014 . Time dependence of elimination of different PEth homologues in alcoholics in comparison with social drinkers. Alcohol. Clin. Exp. Res. 38 : 322 - 326 .
7. Omodeo-Salé, F., C. Lindi, P. Palestini, and M. Masserini . 1991 . Role of phosphatidylethanol in membranes. Effects on membrane fl uidity, tolerance to ethanol, and activity of membranebound enzymes. Biochemistry . 30 : 2477 - 2482 .
8. Pannequin, J., N. Delaunay, C. Darido, T. Maurice, P. Crespy, M. A. Frohman, M. S. Balda, K. Matter, D. Joubert, J. F. Bourgaux, et al . 2007 . Phosphatidylethanol accumulation promotes intestinal hyperplasia by inducing ZONAB-mediated cell density increase in response to chronic ethanol exposure. Mol. Cancer Res. 5 : 1147 - 1157 .
9. Skippen, A., D. H. Jones, C. P. Morgan, M. Li, and S. Cockcroft . 2002 . Mechanism of ADP ribosylation factor-stimulated phosphatidylinositol 4, 5-bisphosphate synthesis in HL60 cells. J. Biol. Chem. 277 : 5823 - 5831 .
10. Sato, T., T. Hongu, M. Sakamoto, Y. Funakoshi, and Y. Kanaho . 2013 . Molecular mechanisms of N-formyl-methionyl-leucylphenylalanine- induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable. Mol. Cell. Biol. 33 : 136 - 145.
11. Arun, S. N., D. Xie, A. C. Howard, Q. Zhong, X. Zhong, P. L. McNeil, and W. B. Bollag . 2013 . Cell wounding activates phospholipase D in primary mouse keratinocytes. J. Lipid Res. 54 : 581 - 591.
12. Bollag, W. B., D. Xie, X. Zheng, and X. Zhong . 2007 . A potential role for the phospholipase D2-aquaporin-3 signaling module in early keratinocyte differentiation: production of a phosphatidylglycerol signaling lipid. J. Invest. Dermatol. 127 : 2823 - 2831 .
13. Choi, S. Y., P. Huang, G. M. Jenkins, D. C. Chan, J. Schiller, and M. A. Frohman . 2006 . A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. Nat. Cell Biol. 8 : 1255 - 1262 .
14. Voigt, F., M. Reuter, A. Kasaruho, E. C. Schulz, R. S. Pillai, and O. Barabas . 2012 . Crystal structure of the primary piRNA biogenesis factor Zucchini reveals similarity to the bacterial PLD endonuclease Nuc. RNA . 18 : 2128 - 2134 .
15. Huang, H. Y., Q. Gao, X. X. Peng, S. Y. Choi, K. Sarma, H. M. Ren, A. J. Morris, and M. A. Frohman . 2011 . piRNA-associated germline nuage formation and spermatogenesis require MitoPLD profusogenic mitochondrial-surface lipid signaling. Dev. Cell . 20 : 376 - 387 .
16. Hammond, S. M., Y. M. Altshuller, T. C. Sung, S. A. Rudge, K. Rose, J. Engebrecht, A. J. Morris, and M. A. Frohman . 1995 . Human ADP-ribosylation factor-activated phosphatidylcholinespecifi c phospholipase D defi nes a new and highly conserved gene family. J. Biol. Chem. 270 : 29640 - 29643 .
17. Colley, W. C., T. C. Sung, R. Roll, J. Jenco, S. M. Hammond, Y. Altshuller, D. Bar-Sagi, A. J. Morris, and M. A. Frohman . 1997 . Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol. 7 : 191 - 201 .
18. Du, G., Y. M. Altshuller, Y. Kim, J. M. Han, S. H. Ryu, A. J. Morris, and M. A. Frohman . 2000 . Dual requirement for rho and protein kinase C in direct activation of phospholipase D1 through G protein-coupled receptor signaling. Mol. Biol. Cell . 11 : 4359 - 4368 .
19. Hammond, S. M., J. M. Jenco, S. Nakashima, K. Cadwallader, Q. Gu, S. Cook, Y. Nozawa, G. D. Prestwich, M. A. Frohman, and A. J. Morris . 1997 . Characterization of two alternately spliced forms of phospholipase D1. Activation of the purifi ed enzymes by phosphatidylinositol 4, 5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-alpha. J. Biol. Chem. 272 : 3860 - 3868 .
20. Bruntz, R. C., C. W. Lindsley, and H. A. Brown . 2014 . Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer. Pharmacol. Rev. 66 : 1033 - 1079 .
21. Leiros, I., F. Secundo, C. Zambonelli, S. Servi, and E. Hough . 2000 . The first crystal structure of a phospholipase D. Structure . 8 : 655 - 667 .
22. Du, G., Y. M. Altshuller, N. Vitale, P. Huang, S. Chasserot-Golaz, A. J. Morris, M. F. Bader, and M. A. Frohman . 2003 . Regulation of phospholipase D1 subcellular cycling through coordination of multiple membrane association motifs. J. Cell Biol. 162 : 305 - 315 .
23. Sciorra, V. A., S. A. Rudge, J. Y. Wang, S. McLaughlin, J. Engebrecht, and A. J. Morris . 2002 . Dual role for phosphoinositides in regulation of yeast and mammalian phospholipase D enzymes. J. Cell Biol. 159 : 1039 - 1049 .
24. Jang, J. H., C. S. Lee, D. Hwang, and S. H. Ryu . 2012 . Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners. Prog. Lipid Res. 51 : 71 - 81 .
25. Sugars, J. M., S. Cellek, M. Manifava, J. Coadwell, and N. T. Ktistakis . 2002 . Hierarchy of membrane-targeting signals of phospholipase D1 involving lipid modifi cation of a pleckstrin homology domain. J. Biol. Chem. 277 : 29152 - 29161.
26. Stahelin, R. V., B. Ananthanarayanan, N. R. Blatner, S. Singh, K. S. Bruzik, D. Murray, and W. H. Cho . 2004 . Mechanism of membrane binding of the phospholipase D1 PX domain. J. Biol. Chem. 279 : 54918 - 54926 .
27. Sung, T. C., Y. Zhang, A. J. Morris, and M. A. Frohman . 1999 . Structural analysis of human phospholipase D1. J. Biol. Chem. 274 : 3659 - 3666 .
28. Elvers, M., D. Stegner, I. Hagedorn, C. Kleinschnitz, A. Braun, M. E. Kuijpers, M. Boesl, Q. Chen, J. W. Heemskerk, G. Stoll, et al . 2010 . Impaired alpha(IIb)beta(3) integrin activation and sheardependent thrombus formation in mice lacking phospholipase D1. Sci. Signal. 3 : ra1 .
29. Munck, A., C. Bohm, N. M. Seibel, Z. Hashemol Hosseini, and W. Hampe . 2005 . Hu-K4 is a ubiquitously expressed type 2 transmembrane protein associated with the endoplasmic reticulum. FEBS J. 272 : 1718 - 1726 .
30. Pedersen, K. M., B. Finsen, J. E. Celis, and N. A. Jensen . 1998 . Expression of a novel murine phospholipase D homolog coincides with late neuronal development in the forebrain. J. Biol. Chem. 273 : 31494 - 31504.
31. Kent, D. G., M. R. Copley, C. Benz, S. Wohrer, B. J. Dykstra, E. Ma, J. Cheyne, Y. J. Zhao, M. B. Bowie, Y. Zhao, et al . 2009 . Prospectiveisolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential. Blood . 113 : 6342 - 6350.
32. Osisami, M., W. Ali, and M. A. Frohman . 2012 . A role for phospholipase D3 in myotube formation. PLoS ONE . 7 : E33341.
33. Zhang, J., S. Chen, S. Zhang, Z. Lu, H. Yang, and H. Wang . 2009 . Over-expression of phospholipase D3 inhibits Akt phosphorylation in C2C12 myoblasts [article in Chinese]. Sheng Wu Gong Cheng Xue Bao . 25 : 1524 - 1531 .
34. Yoshikawa, F., Y. Banno, Y. Otani, Y. Yamaguchi, Y. Nagakura- Takagi, N. Morita, Y. Sato, C. Saruta, H. Nishibe, T. Sadakata, et al . 2010 . Phospholipase D family member 4, a transmembrane glycoprotein with no phospholipase D activity, expression in spleen and early postnatal microglia. PLoS ONE . 5 : E13932 .
35. Zhao, Y., J. A. Stuckey, D. L. Lohse, and J. E. Dixon . 1997 . Expression, characterization, and crystallization of a member of the novel phospholipase D family of phosphodiesterases. Protein Sci. 6 : 2655 - 2658 .
36. Reue, K., and J. R. Dwyer . 2009 . Lipin proteins and metabolic homeostasis. J. Lipid Res. 50 : S109 - S114 .
37. Stegner, D., I. Thielmann, P. Kraft, M. A. Frohman, G. Stoll, and B. Nieswandt . 2013 . Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke-brief report. Arterioscler. Thromb. Vasc. Biol. 33 : 2212 - 2217 .
38. Schönberger, T., T. Jürgens, J. Müller, N. Armbruster, C. Niermann, S. Gorressen, J. Sommer, H. Tian, G. di Paolo, J. Scheller, et al . 2014 . Pivotal role of phospholipase D1 in tumor necrosis factor-alpha-mediated infl ammation and scar formation after myocardial ischemia and reperfusion in mice. Am. J. Pathol. 184 : 2450 - 2464 .
39. Chen, Q., T. Hongu, T. Sato, Y. Zhang, W. Ali, J. A. Cavallo, A. van der Velden, H. Tian, G. Di Paolo, B. Nieswandt, et al . 2012 . Key roles for the lipid signaling enzyme phospholipase d1 in the tumor microenvironment during tumor angiogenesis and metastasis. Sci. Signal. 5 : ra79 .
40. Gobel, K., M. K. Schuhmann, S. Pankratz, D. Stegner, A. M. Herrmann, A. Braun, J. Breuer, S. Bittner, T. Ruck, H. Wiendl, et al . 2014 . Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 44 : 2295 - 2305 .
41. Dhingra, S., M. E. Rodriguez, Q. Shen, X. Duan, M. L. Stanton, L. Chen, R. Zhang, and R. E. Brown . 2011 . Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications. Int. J. Clin. Exp. Pathol. 4 : 134 - 146 .
42. Gozgit, J. M., B. T. Pentecost, S. A. Marconi, R. S. Ricketts-Loriaux, C. N. Otis, and K. F. Arcaro . 2007 . PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Aktnegative breast carcinomas. Br. J. Cancer . 97 : 809 - 817 .
43. Shen, Q., M. L. Stanton, W. Feng, M. E. Rodriguez, L. Ramondetta, L. Chen, R. E. Brown, and X. Duan . 2010 . Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma. Int. J. Clin. Exp. Pathol. 4 : 13 - 21.
44. Omuro, A., and L. M. DeAngelis . 2013 . Glioblastoma and other malignant gliomas: A clinical review. JAMA . 310 : 1842 - 1850 .
45. Wen, P. Y., and S. Kesari . 2008 . Malignant gliomas in adults. N. Engl. J. Med. 359 : 492 - 507 .
46. Oike, T., Y. Suzuki, K. Sugawara, K. Shirai, S. E. Noda, T. Tamaki, M. Nagaishi, H. Yokoo, Y. Nakazato, and T. Nakano . 2013 . Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results. PLoS ONE . 8 : E78943 .
47. O'Reilly, M. C., S. A. Scott, K. A. Brown, T. H. Oguin 3rd, P. G. Thomas, J. S. Daniels, R. Morrison, H. A. Brown, and C. W. Lindsley . 2013 . Development of dual PLD1/2 and PLD2 selective inhibitors from a common 1, 3, 8-triazaspiro[4.5]decane core: discovery of Ml298 and Ml299 that decrease invasive migration in U87-MG glioblastoma cells. J. Med. Chem. 56 : 2695 - 2699 .
48. Sayyah, J., A. Bartakova, N. Nogal, L. A. Quilliam, D. G. Stupack, and J. H. Brown . 2014 . The Ras-related protein, Rap1A, mediates thrombin-stimulated, integrin-dependent glioblastoma cell proliferation and tumor growth. J. Biol. Chem. 289 : 17689 - 17698 .
49. Bruntz, R. C., H. E. Taylor, C. W. Lindsley, and H. A. Brown . 2014 . Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells. J. Biol. Chem. 289 : 600 - 616.
50. Han, S., J. Huh, W. Kim, S. Jeong, S. Min do, and Y. Jung . 2014 . Phospholipase D activates HIF-1-VEGF pathway via phosphatidic acid. Exp. Mol. Med. 46 : E126 .
51. Park, M. H., B. H. Ahn, Y. K. Hong, and S. Min do . 2009 . Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways. Carcinogenesis . 30 : 356 - 365 .
52. Chen, Z., D. Li, Q. Cheng, Z. Ma, B. Jiang, R. Peng, R. Chen, Y. Cao, and X. Wan . 2014 . MicroRNA-203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2. Mol. Med. Rep. 9 : 503 - 508 .
53. Su, W. O. Yeku, S. Olepu, A. Genna, J. S. Park, H. Ren, G. Du, M. H. Gelb, A. J. Morris, and M. A. Frohman . 2009 . 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol. Pharmacol. 75 : 437 - 446.
54. Seo, H. Y., B. K. Jang, Y. A. Jung, E. J. Lee, H. S. Kim, J. H. Jeon, J. G. Kim, I. K. Lee, M. K. Kim, and K. G. Park . 2014 . Phospholipase D1 decreases type I collagen levels in hepatic stellate cells via induction of autophagy. Biochem. Biophys. Res. Commun. 449 : 38 - 43 .
55. Zhu, X., R. Liu, D. Kuang, J. Liu, X. Shi, T. Zhang, Y. Zeng, X. Sun, Y. Zhang, and W. Yang . 2014 . The role of phospholipase D1 in liver fi brosis induced by dimethylnitrosamine in vivo. Dig. Dis. Sci. 59 : 1779 - 1788 .
56. Patel, R. B., S. R. Kotha, S. I. Sherwani, S. M. Sliman, T. O. Gurney, B. Loar, S. O. Butler, A. J. Morris, C. B. Marsh, and N. L. Parinandi . 2011 . Pulmonary fi brosis inducer, bleomycin, causes redox-sensitive activation of phospholipase D and cytotoxicity through formation of bioactive lipid signal mediator, phosphatidic acid, in lung microvascular endothelial cells. Int. J. Toxicol. 30 : 69 - 90 .
57. Dent, M. R., T. Singal, N. S. Dhalla, and P. S. Tappia . 2004 . Expression of phospholipase D isozymes in scar and viable tissue in congestive heart failure due to myocardial infarction. J. Cell. Mol. Med. 8 : 526 - 536 .
58. Tappia, P. S., and N. S. Dhalla . 2014 . Alterations in phospholipase D during the development of myocardial disease. In Phospholipases in Health and Disease. Vol. 10. P. S. Tappia and N. S. Dhalla, editors. Springer-Verlag, New York. 381 - 393 .
59. Dall'Armi, C., A. Hurtado-Lorenzo, H. S. Tian, E. Morel, A. Nezu, R. B. Chan, W. H. Yu, K. S. Robinson, O. Yeku, S. A. Small, et al . 2010 . The phospholipase D1 pathway modulates macroautophagy. Nat. Commun. 1 : 142 .
60. Bae, E. J., H. J. Lee, Y. H. Jang, S. Michael, E. Masliah, D. S. Min, and S. J. Lee . 2014 . Phospholipase D1 regulates autophagic fl ux and clearance of alpha-synuclein aggregates. Cell Death Differ. 21 : 1132 - 1141 .
61. Rautou, P. E., A. Mansouri, D. Lebrec, F. Durand, D. Valla, and R. Moreau . 2010 . Autophagy in liver diseases. J. Hepatol. 53 : 1123 - 1134 .
62. Levine, B., and G. Kroemer . 2008 . Autophagy in the pathogenesis of disease. Cell . 132 : 27 - 42 .
63. Domart, M. C., D. Degli Esposti, M. Sebagh, N. Olaya, F. Harper, G. Pierron, B. Franc, K. K. Tanabe, B. Debuire, D. Azoulay, et al . 2009 . Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy. J. Hepatol. 51 : 881 - 889 .
64. Yamamoto, K., Y. Takahashi, T. Mano, Y. Sakata, N. Nishikawa, J. Yoshida, Y. Oishi, M. Hori, T. Miwa, S. Inoue, et al . 2004 . N-methylethanolamine attenuates cardiac fi brosis and improves diastolic function: inhibition of phospholipase D as a possible mechanism. Eur. Heart J. 25 : 1221 - 1229 .
65. Ali, W. H., Q. Chen, K. E. Delgiorno, W. Su, J. C. Hall, T. Hongu, H. Tian, Y. Kanaho, G. Di Paolo, H. C. Crawford, et al . 2013 . Defi ciencies of the lipid-signaling enzymes phospholipase D1 and D2 alter cytoskeletal organization, macrophage phagocytosis, and cytokine-stimulated neutrophil recruitment. PLoS ONE . 8 : E55325 .
66. Hong, K. W., H. S. Jin, J. E. Lim, Y. S. Cho, M. J. Go, J. Jung, J. E. Lee, J. Choi, C. Shin, S. Y. Hwang, et al . 2010 . Non-synonymous single-nucleotide polymorphisms associated with blood pressure and hypertension. J. Hum. Hypertens. 24 : 763 - 774 .
67. Ghim, J., J. S. Moon, C. S. Lee, J. Lee, P. Song, A. Lee, J. H. Jang, D. Kim, J. H. Yoon, Y. J. Koh, et al . 2014 . Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis. Arterioscler. Thromb. Vasc. Biol. 34 : 1697 - 1703.
68. Henkels, K. M., G. P. Boivin, E. S. Dudley, S. J. Berberich, J. Gomez-Cambronero, and D. Phospholipase . 2013 . PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model. Oncogene . 32 : 5551 - 5562 .
69. Oliveira, T. G., R. B. Chan, H. Tian, M. Laredo, G. Shui, A. Staniszewski, H. Zhang, L. Wang, T. W. Kim, K. E. Duff, et al . 2010 . Phospholipase d2 ablation ameliorates Alzheimer's diseaselinked synaptic dysfunction and cognitive defi cits. J. Neurosci. 30 : 16419 - 16428 .
70. Horimoto, T., and Y. Kawaoka . 2005 . Infl uenza: lessons from past pandemics, warnings from current incidents. Nat. Rev. Microbiol. 3 : 591 - 600 .
71. Neumann, G., T. Noda, and Y. Kawaoka . 2009 . Emergence and pandemic potential of swine-origin H1N1 infl uenza virus. Nature . 459 : 931 - 939 .
72. Dong, G., C. Peng, J. Luo, C. Wang, L. Han, B. Wu, G. Ji, and H. He . 2015 . Adamantane-resistant infl uenza a viruses in the world (1902-2013): frequency and distribution of m2 gene mutations. PLoS ONE . 10 : E0119115.
73. Karlas, A., N. Machuy, Y. Shin, K. P. Pleissner, A. Artarini, D. Heuer, D. Becker, H. Khalil, L. A. Ogilvie, S. Hess, et al . 2010 . Genome-wide RNAi screen identifi es human host factors crucial for infl uenza virus replication. Nature . 463 : 818 - 822 .
74. Oguin 3rd, T. H., S. Sharma, A. D. Stuart, S. Duan, S. A. Scott, C. K. Jones, J. S. Daniels, C. W. Lindsley, P. G. Thomas, and H. A. Brown . 2014 . Phospholipase D facilitates effi cient entry of infl uenza virus, allowing escape from innate immune inhibition. J. Biol. Chem. 289 : 25405 - 25417.
75. Uchida, N., S. Okamura, and H. Kuwano . 1999 . Phospholipase D activity in human gastric carcinoma. Anticancer Res. 19 ( 1B ): 671 - 675 .
76. Yamada, Y., N. Hamajima, T. Kato, H. Iwata, Y. Yamamura, M. Shinoda, M. Suyama, T. Mitsudomi, K. Tajima, S. Kusakabe, et al . 2003 . Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer. J. Mol. Med. (Berl) . 81 : 126 - 131 .
77. Toschi, A., J. Edelstein, P. Rockwell, M. Ohh, and D. A. Foster . 2008 . HIF alpha expression in VHL-defi cient renal cancer cells is dependent on phospholipase D. Oncogene . 27 : 2746 - 2753 .
78. Saito, M., M. Iwadate, M. Higashimoto, K. Ono, Y. Takebayashi, and S. Takenoshita . 2007 . Expression of phospholipase D2 in human colorectal carcinoma. Oncol. Rep. 18 : 1329 - 1334 .
79. Liu, M., K. Du, Z. Fu, S. Zhang, and X. Wu . 2015 . Hypoxiainducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions. Med. Oncol. 32 : 394 .
80. Cai, D., W. J. Netzer, M. Zhong, Y. Lin, G. Du, M. Frohman, D. A. Foster, S. S. Sisodia, H. Xu, F. S. Gorelick, et al . 2006 . Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation. Proc. Natl. Acad. Sci. USA . 103 : 1941 - 1946 .
81. Cruchaga, C., C. M. Karch, S. C. Jin, B. A. Benitez, Y. Cai, R. Guerreiro, O. Harari, J. Norton, J. Budde, S. Bertelsen, et al . 2014 . Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature . 505 : 550 - 554 .
82. Lein, E. S., M. J. Hawrylycz, N. Ao, M. Ayres, A. Bensinger, A. Bernard, A. F. Boe, M. S. Boguski, K. S. Brockway, E. J. Byrnes, et al . 2007 . Genome-wide atlas of gene expression in the adult mouse brain. Nature . 445 : 168 - 176 .
83. Hawrylycz, M. J., E. S. Lein, A. L. Guillozet-Bongaarts, E. H. Shen, L. Ng, J. A. Miller, L. N. van de Lagemaat, K. A. Smith, A. Ebbert, Z. L. Riley, et al . 2012 . An anatomically comprehensive atlas of the adult human brain transcriptome. Nature . 489 : 391 - 399 .
84. Kong, W., X. Mou, Q. Liu, Z. Chen, C. R. Vanderburg, J. T. Rogers, and X. Huang . 2009 . Independent component analysis of Alzheimer's DNA microarray gene expression data. Mol. Neurodegener. 4 : 5 .
85. Chadwick, W, Brenneman R, Martin B, Maudsley S. Complex and multidimensional lipid raft alterations in a murine model of Alzheimer's disease . Int J Alzheimers Dis . 2010; 2010 : 604792 .
86. Morel, E., Z. Chamoun, Z. M. Lasiecka, R. B. Chan, R. L. Williamson, C. Vetanovetz, C. Dall'Armi, S. Simoes, K. S. Point Du Jour, B. D. McCabe, et al . 2013 . Phosphatidylinositol-3-phosphate regulates sorting and processing of amyloid precursor protein through the endosomal system. Nat. Commun. 4 : 2250.
87. Small, S. A., and S. Gandy . 2006 . Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis. Neuron . 52 : 15 - 31 .
88. Pridgeon, J. W., E. A. Webber, D. Sha, L. Li, and L. S. Chin . 2009 . Proteomic analysis reveals Hrs ubiquitin-interacting motif-mediated ubiquitin signaling in multiple cellular processes. FEBS J. 276 : 118 - 131 .
89. Brunner, Y., Y. Coute, M. Iezzi, M. Foti, M. Fukuda, D. F. Hochstrasser, C. B. Wollheim, and J. C. Sanchez . 2007 . Proteomics analysis of insulin secretory granules. Mol. Cell. Proteomics . 6 : 1007 - 1017 .
90. Palmieri, M., S. Impey, H. Kang, A. di Ronza, C. Pelz, M. Sardiello, and A. Ballabio . 2011 . Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum. Mol. Genet. 20 : 3852 - 3866 .
91. Lee, K. A., L. P. Hammerle, P. S. Andrews, M. P. Stokes, T. Mustelin, J. C. Silva, R. A. Black, and J. R. Doedens . 2011 . Ubiquitin ligase substrate identifi cation through quantitative proteomics at both the protein and peptide levels. J. Biol. Chem. 286 : 41530 - 41538 .
92. Liu, B., Y. Zheng, T. D. Wang, H. Z. Xu, L. Xia, J. Zhang, Y. L. Wu, G. Q. Chen, and L. S. Wang . 2012 . Proteomic identifi cation of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells. J. Proteome Res. 11 : 1773 - 1781 .
93. Shi, Y., D. W. Chan, S. Y. Jung, A. Malovannaya, Y. Wang, and J. Qin . 2011 . A data set of human endogenous protein ubiquitination sites . Mol. Cell. Proteomics . 10 : 002089 .
94. Adzhubei, I. A., S. Schmidt, L. Peshkin, V. E. Ramensky, A. Gerasimova, P. Bork, A. S. Kondrashov, and S. R. Sunyaev . 2010 . A method and server for predicting damaging missense mutations. Nat. Methods . 7 : 248 - 249 .
95. Heilmann, S., D. Drichel, J. Clarimon, V. Fernandez, A. Lacour, H. Wagner, M. Thelen, I. Hernandez, J. Fortea, M. Alegret, et al . 2015 . PLD3 in non-familial Alzheimer's disease. Nature . 520 : E3 - E5 .
96. Hooli, B. V., C. M. Lill, K. Mullin, D. Qiao, C. Lange, L. Bertram, and R. E. Tanzi . 2015 . PLD3 gene variants and Alzheimer's disease. Nature . 520 : E7 - E8 .
97. Lambert, J. C., B. Grenier-Boley, C. Bellenguez, F. Pasquier, D. Campion, J. F. Dartigues, C. Berr, C. Tzourio, and P. Amouyel . 2015 . PLD3 and sporadic Alzheimer's disease risk. Nature . 520 : E1 .
98. Otani, Y., Y. Yamaguchi, Y. Sato, T. Furuichi, K. Ikenaka, H. Kitani, and H. Baba . 2011 . PLD4 is involved in phagocytosis of microglia: Expression and localization changes of PLD4 are correlated with activation state of microglia. PLoS ONE . 6 : E27544.
99. Jung, S., H. Pausch, M. C. Langenmayer, H. Schwarzenbacher, M. Majzoub-Altweck, N. S. Gollnick, and R. Fries . 2014 . A nonsense mutation in PLD4 is associated with a zinc defi ciency-like syndrome in Fleckvieh cattle. BMC Genomics . 15 : 623 .
100. Okada, Y., C. Terao, K. Ikari, Y. Kochi, K. Ohmura, A. Suzuki, T. Kawaguchi, E. A. Stahl, F. A. Kurreeman, N. Nishida, et al . 2012 . Meta-analysis identifi es nine new loci associated with rheumatoid arthritis in the Japanese population. Nat. Genet. 44 : 511 - 516 .
101. Terao, C., K. Ohmura, Y. Kawaguchi, T. Nishimoto, A. Kawasaki, K. Takehara, H. Furukawa, Y. Kochi, Y. Ota, K. Ikari, et al . 2013 . PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population. Arthritis Rheum. 65 : 472 - 480 .
102. Aissani, B., H. Wiener, and K. Zhang . 2013 . Multiple hits for the association of uterine fi broids on human chromosome 1q43. PLoS ONE . 8 : E58399.
103. Cook, E. H. Jr ., and S. W. Scherer . 2008 . Copy-number variations associated with neuropsychiatric conditions. Nature . 455 : 919 - 923 .
104. Lord, C., M. Rutter, and A. Le Couteur . 1994 . Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J. Autism Dev. Disord. 24 : 659 - 685 .
105. Lord, C., S. Risi, L. Lambrecht, E. H. Cook, Jr ., B. L. Leventhal, P. C. DiLavore, A. Pickles, and M. Rutter . 2000 . The autism diagnostic observation schedule-generic: A standard measure of social and communication defi cits associated with the spectrum of autism. J. Autism Dev. Disord. 30 : 205 - 223 .
106. Anney, R., L. Klei, D. Pinto, R. Regan, J. Conroy, T. R. Magalhaes, C. Correia, B. S. Abrahams, N. Sykes, A. T. Pagnamenta, et al . 2010 . A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 19 : 4072 - 4082 .
107. Uleberg, K. E., A. C. Munk, I. Skaland, C. Furlan, B. van Diermen, E. Gudlaugsson, E. A. Janssen, A. Malpica, W. Feng, A. Hjelle, et al . 2011 . A protein profi le study to discriminate CIN lesions from normal cervical epithelium443 - 450. Cell. Oncol. (Dordr) . 34 :.
108. Uleberg, K. E., I. T. Ovestad, A. C. Munk, C. Brede, B. van Diermen, E. Gudlaugsson, E. A. Janssen, A. Hjelle, and J. P. Baak . 2014 . Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis. Int. J. Proteomics . 2014 : 129064 .
109. Jemal, A., F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman . 2011 . Global cancer statistics. CA Cancer J. Clin. 61 : 69 - 90 .
110. zur Hausen, H. 2009 . Papillomaviruses in the causation of human cancers - A brief historical account. Virology . 384 : 260 - 265 .
111. Walboomers, J. M. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. F. Snijders, J. Peto, C. J. L. M. Meijer, and N. Munoz . 1999 . Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 : 12 - 19 .
112. Insinga, R. P., E. J. Dasbach, and E. H. Elbasha . 2009 . Epidemiologic natural history and clinical management of human papillomavirus (HPV) disease: A critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect. Dis. 9 : 119 .
113. World Health Organization. 2013 . WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. World Health Organization, Geneva . PMID: 24716265.
114. Ostör, A. G. 1993 . Natural history of cervical intraepithelial neoplasia: A critical review. Int. J. Gynecol. Pathol. 12 : 186 - 192 .
115. Lu, Y., C. Li, K. Zhang, H. Sun, D. Tao, Y. Liu, S. Zhang, and Y. Ma . 2010 . Identifi cation of piRNAs in Hela cells by massive parallel sequencing. BMB Rep. 43 : 635 - 641 .
116. Teng, S., D. Stegner, Q. Chen, T. Hongu, H. Hasegawa, L. Chen, Y. Kanaho, B. Nieswandt, M. A. Frohman, and P. Huang . 2015 . Phospholipase D1 facilitates second-phase myoblast fusion and skeletal muscle regeneration. Mol. Biol. Cell . 26 : 506 - 517 .